Investigational Site Number :1560041

Hefei 233004

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Chronic Obstructive Pulmonary Disease

Studies at this site

• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation — Completed